STOP BLEEDING wounds in SECONDS; 100 MILLION US Dollars Raised! with Joe Landolina, CEO Co-Founder of Cresilon| Episode 13 (Part 1)

At 17, Joe invented a Gel that prevents excessive wound blood loss (Patent #: BR112014011442A8).  This led to the creation of Cresilon. The company recently got FDA Approved. Raising 100 MILLION USD Dollars along the way!! He was also listed on the Forbes 30 under 30 for 2023 North America ( https://www.forbes.com/30-under-30/2023/healthcare?profile=joe-landolina )
This is an Exciting Discussion covering many points!!

TIMESTAMP:
00:00 Intro
01:59 Joe Landolina’s Background
04:10 Public Speaking Skills
05:25 Cresilon Gel Working principle
08:05 How the gel is delivered to healthcare professionals
08:35 Shelf Life of the Cresilon’s Vetigel
09:22 Basic biological principles of a blood clot
10:14 How Cresilon’s Gels help the body stop bleeds without removing the natural seal when the gel is removed
12:15 Strategy with creating a product for animals first
14:55 FDA Approved For Human Use. Cresilon Hemostatic Gel (CHG)!
17:40 Risk Classification of CHG
18:56 Building up Cresilon from dorm room to 100 million VC raised funds
23:45 Current manufacturing capacity
24:25 Traits to handle a start-up
26:07 How to Raise 100 Million US Dollars from Venture Capital
29:51 Transferable skills from a STEM background to Finance or start-up-related skill requirements
32:00 CHG infrastructure
34:41 Reaction Process
36:49 Market Launch for CHG

Cresilon Links:
https://cresilon.com/
https://www.forbes.com/profile/joe-landolina/?list=30under30-healthcare%2F